161 related articles for article (PubMed ID: 28614243)
1. Different types of glomerulonephritis associated with the dysregulation of the complement alternative pathway in 2 brothers: A case report.
Chen P; Zhu L; Yu F; Han SS; Meng SJ; Guo WY; Zhang H; Song Y
Medicine (Baltimore); 2017 Jun; 96(24):e7144. PubMed ID: 28614243
[TBL] [Abstract][Full Text] [Related]
2. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
3. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
[TBL] [Abstract][Full Text] [Related]
4. C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.
Garg N; Zhang Y; Nicholson-Weller A; Khankin EV; Borsa NG; Meyer NC; McDermott S; Stillman IE; Rennke HG; Smith RJ; Pavlakis M
Nephrol Dial Transplant; 2018 Dec; 33(12):2260-2265. PubMed ID: 29370420
[TBL] [Abstract][Full Text] [Related]
5. C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report.
Wen J; Wang W; Xu F; Sun J; Chen J; Ni X
BMC Nephrol; 2018 Jun; 19(1):148. PubMed ID: 29940891
[TBL] [Abstract][Full Text] [Related]
6. C3 glomerulonephritis and CFHR5 nephropathy.
Gale DP; Maxwell PH
Nephrol Dial Transplant; 2013 Feb; 28(2):282-8. PubMed ID: 23125424
[TBL] [Abstract][Full Text] [Related]
7. C3 glomerulopathy: what's in a name?
D'Agati VD; Bomback AS
Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
[TBL] [Abstract][Full Text] [Related]
8. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.
Fang CJ; Fremeaux-Bacchi V; Liszewski MK; Pianetti G; Noris M; Goodship TH; Atkinson JP
Blood; 2008 Jan; 111(2):624-32. PubMed ID: 17914026
[TBL] [Abstract][Full Text] [Related]
9. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
[TBL] [Abstract][Full Text] [Related]
10. Complement dysregulation in glomerulonephritis.
Kaartinen K; Safa A; Kotha S; Ratti G; Meri S
Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769
[TBL] [Abstract][Full Text] [Related]
11. Co-existence of Alport syndrome and C3 glomerulonephritis in a proband with family history.
Ding Y; Tang X; Du Y; Chen H; Yu D; Zhu B; Yuan B
Eur J Med Res; 2021 Jul; 26(1):71. PubMed ID: 34238373
[TBL] [Abstract][Full Text] [Related]
12. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
Boyer O; Noël LH; Balzamo E; Guest G; Biebuyck N; Charbit M; Salomon R; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
[TBL] [Abstract][Full Text] [Related]
13. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
Kersnik Levart T; Ferluga D; Vizjak A; Mraz J; Kojc N
Diagn Pathol; 2016 Oct; 11(1):94. PubMed ID: 27717365
[TBL] [Abstract][Full Text] [Related]
14. Redefining C3 glomerulopathy: 'C3 only' is a bridge too far.
Larsen CP; Walker PD
Kidney Int; 2013 Feb; 83(2):331-2. PubMed ID: 23364589
[No Abstract] [Full Text] [Related]
15. Kidney Transplantation in C3 Glomerulopathy: A Case Series.
Regunathan-Shenk R; Avasare RS; Ahn W; Canetta PA; Cohen DJ; Appel GB; Bomback AS
Am J Kidney Dis; 2019 Mar; 73(3):316-323. PubMed ID: 30413277
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
17. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
[TBL] [Abstract][Full Text] [Related]
18. Alternative complement pathway assessment in patients with atypical HUS.
Roumenina LT; Loirat C; Dragon-Durey MA; Halbwachs-Mecarelli L; Sautes-Fridman C; Fremeaux-Bacchi V
J Immunol Methods; 2011 Feb; 365(1-2):8-26. PubMed ID: 21215749
[TBL] [Abstract][Full Text] [Related]
19. C3 Glomerulonephritis With Multiple Mutations in Complement Factor H.
Dalili N; Behnam B; Vali F; Parvin M; Torbati P; Rasaii N; Samadian F; Ahmadpoor P
Iran J Kidney Dis; 2018 Nov; 12(6):376-381. PubMed ID: 30595568
[TBL] [Abstract][Full Text] [Related]
20. Atypical hemolytic uremic syndrome.
Loirat C; Frémeaux-Bacchi V
Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
